search
Back to results

Fetal Surgery for Moderate Left Sided Congenital Diaphragmatic Hernia. (TOTAL moderate)

Primary Purpose

Congenital Diaphragmatic Hernia, Fetal Surgery, Pulmonary Hypoplasia

Status
Completed
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Fetoscopic Endoluminal Tracheal Occlusion
Sponsored by
University Hospital, Gasthuisberg
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Congenital Diaphragmatic Hernia focused on measuring congenital diaphragmatic hernia, fetal surgery, pulmonary hypoplasia, observed/expected lung to head ratio, liver position, feto, fetoscopic endoluminal tracheal occlusion, standardized neonatal care

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients aged 18 years or more, who are able to consent
  • Singleton pregnancy
  • Anatomically and chromosomally normal fetus
  • Left sided diaphragmatic hernia
  • Gestation at randomization prior to 31 wks plus 5 d (so that occlusion is done at the latest on 31 wks plus 6 d)
  • Estimated to have moderate pulmonary hypoplasia, defined prenatally as:

    • O/E LHR 25-34.9% (included; irrespective of the position of the liver)
    • O/E LHR 35-44.9% (included) with intrathoracic liver herniation as determined by ultrasound or MRI
  • Acceptance of randomization and the consequences for the further management during pregnancy and thereafter.
  • The patients must undertake the responsibility for either remaining close to, or at the FETO center, or being able to travel swiftly and within acceptable time interval to the FETO center until the balloon is removed.
  • Intended postnatal treatment center must subscribe to suggested guidelines for "standardized postnatal treatment".
  • Provide written consent to participate in this RCT

Exclusion Criteria:

  • Maternal contraindication to fetoscopic surgery or severe medical condition in pregnancy that make fetal intervention risk full
  • Technical limitations precluding fetoscopic surgery, such as severe maternal obesity, uterine fibroids or potentially others, not anticipated at the time of writing this protocol.
  • Preterm labour, cervix shortened (<15 mm at randomization) or uterine anomaly strongly predisposing to preterm labour, placenta previa
  • Patient age less than 18 years
  • Psychosocial ineligibility, precluding consent
  • Diaphragmatic hernia: right-sided or bilateral, major anomalies, isolated left-sided outside the O/E LHR limits for the inclusion criteria
  • Patient refusing randomization or to comply with return to FETO center during the time period the airways are occluded or for elective removal of the balloon

Sites / Locations

  • Baylor College of Medicine/Texas Children's Hospital
  • University of Texas Health Science Center
  • Mater Mother's Hospital
  • University Hospitals Leuven
  • Mount Sinai Hospital
  • Hôpital Antoine Béclère
  • Hôpital Necker - Enfants Malades
  • University Hospital of Bonn
  • Ospedale Maggiore Policlinico
  • Ospedale Pediatrico Bambino Gesù
  • 1st Department of Obstetrics and Gynecology, Medical University of Warsaw
  • Hospital Clinic Barcelona
  • King's College Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

FETO

Expectant management

Arm Description

prenatal FETO at 30-31+6 weeks and removal at 34-34+6 wks, followed by standardized postnatal care

expectant management during pregnancy followed by standardized neonatal care

Outcomes

Primary Outcome Measures

Survival at discharge
Supplemental oxygen at 6 months of age

Secondary Outcome Measures

Grading of oxygen dependency
Pulmonary hypertension
Use of extracorporeal membrane oxygenation
Change in O/E LHR after FETO
NICU days
days of ventilatory support
Periventricular leucomalacia
Neonatal sepsis
Intraventricular hemorrhage
Retinopathy of prematurity
Days until full enteral feeding
Gastroesophageal reflux
Day of postnatal surgery
Use of patch
Defect size
Number of days alive in case of postnatal death

Full Information

First Posted
September 30, 2008
Last Updated
November 30, 2020
Sponsor
University Hospital, Gasthuisberg
Collaborators
King's College Hospital NHS Trust (UK), Hospital Clinic of Barcelona, Hopital Antoine Beclere, Hôpital Necker-Enfants Malades, University Hospital, Bonn, Mater Mothers' Hospital, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Ospedale Pediatrico Bambino Gesù, Rome (IT), Mount Sinai Hospital, Canada, Baylor College of Medicine, The University of Texas Health Science Center, Houston, Medical University of Warsaw
search

1. Study Identification

Unique Protocol Identification Number
NCT00763737
Brief Title
Fetal Surgery for Moderate Left Sided Congenital Diaphragmatic Hernia.
Acronym
TOTAL moderate
Official Title
Randomized Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) Versus Expectant Management During Pregnancy in Fetuses With Left Sided and Isolated Congenital Diaphragmatic Hernia and Moderate Pulmonary Hypoplasia.
Study Type
Interventional

2. Study Status

Record Verification Date
November 2020
Overall Recruitment Status
Completed
Study Start Date
August 2010 (undefined)
Primary Completion Date
March 2020 (Actual)
Study Completion Date
March 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospital, Gasthuisberg
Collaborators
King's College Hospital NHS Trust (UK), Hospital Clinic of Barcelona, Hopital Antoine Beclere, Hôpital Necker-Enfants Malades, University Hospital, Bonn, Mater Mothers' Hospital, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Ospedale Pediatrico Bambino Gesù, Rome (IT), Mount Sinai Hospital, Canada, Baylor College of Medicine, The University of Texas Health Science Center, Houston, Medical University of Warsaw

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Isolated Congenital Diaphragmatic Hernia (CDH) can be diagnosed in the prenatal period, and remains associated with a 30 % chance of perinatal death and morbidity mainly because of pulmonary hypoplasia and pulmonary hypertension. In addition, in the survivors there is a high rate of morbidity with evidence of bronchopulmonary dysplasia in more than 70% of cases. The risk for these can be predicted prenatally by the ultrasonographic measurement of the observed/expected lung area to head circumference ratio (O/E LHR) which is a measure of pulmonary hypoplasia. Also position of the liver is predictive of outcome. The proposing consortium has developed a prenatal therapeutic approach, which consists of percutaneous fetoscopic endoluminal tracheal occlusion (FETO) with subsequent removal of the balloon. Both procedures are performed percutaneously, there is now experience with more than 150 cases and it has been shown to be safe for the mother. We have witnessed an improvement of survival in fetuses with a predicted chance of survival of less than 30% (referred to as fetuses with severe pulmonary hypoplasia; O/E LHR <25% and liver herniation) to 55% on average. Also there is an apparent reduction in morbidity with the rate of bronchopulmonary dysplasia decreasing from the estimated rate of more than 70% to less than 40% in the same severity group. Further we have shown that results of FETO are predicted by LHR measurement prior to the procedure, so that better results can be expected in fetuses with larger lung size. Therefore we now aim to offer FETO to fetuses with moderate CDH (=O/E LHR 25-34.9%, irrespective of the liver position as well as O/E LHR 35-44.9% with intrathoracic herniation of the liver). When managed expectantly the estimated rate of postnatal survival is 55%. This trial will test whether temporary fetoscopic tracheal occlusion rather than expectant management during pregnancy, both followed by standardized postnatal management increases survival or decrease oxygen dependency at 6 months of age. The balloon will be placed between 30 and 31+6 weeks, and will be removed between 34 and 34+6 weeks.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Congenital Diaphragmatic Hernia, Fetal Surgery, Pulmonary Hypoplasia
Keywords
congenital diaphragmatic hernia, fetal surgery, pulmonary hypoplasia, observed/expected lung to head ratio, liver position, feto, fetoscopic endoluminal tracheal occlusion, standardized neonatal care

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
196 (Actual)

8. Arms, Groups, and Interventions

Arm Title
FETO
Arm Type
Experimental
Arm Description
prenatal FETO at 30-31+6 weeks and removal at 34-34+6 wks, followed by standardized postnatal care
Arm Title
Expectant management
Arm Type
No Intervention
Arm Description
expectant management during pregnancy followed by standardized neonatal care
Intervention Type
Procedure
Intervention Name(s)
Fetoscopic Endoluminal Tracheal Occlusion
Intervention Description
prenatal balloon placement at 30-31+6 weeks and removal at 34-34+6 wks
Primary Outcome Measure Information:
Title
Survival at discharge
Time Frame
at the time of discharge from NICU, approximately 2 months
Title
Supplemental oxygen at 6 months of age
Time Frame
at 6 months of age
Secondary Outcome Measure Information:
Title
Grading of oxygen dependency
Time Frame
between 28 and 56 days of life if born >32 weeks; at 36 weeks postmenstrual age if born <32 weeks
Title
Pulmonary hypertension
Time Frame
during NICU admission
Title
Use of extracorporeal membrane oxygenation
Time Frame
during NICU admission
Title
Change in O/E LHR after FETO
Time Frame
prior to unplug
Title
NICU days
Time Frame
during NICU admission
Title
days of ventilatory support
Time Frame
during NICU admission
Title
Periventricular leucomalacia
Time Frame
during NICU admission
Title
Neonatal sepsis
Time Frame
during NICU admission
Title
Intraventricular hemorrhage
Time Frame
during NICU admission
Title
Retinopathy of prematurity
Time Frame
during NICU admission
Title
Days until full enteral feeding
Time Frame
during NICU admission
Title
Gastroesophageal reflux
Time Frame
during NICU admission
Title
Day of postnatal surgery
Time Frame
during NICU admission
Title
Use of patch
Time Frame
at the time of postnatal surgery
Title
Defect size
Time Frame
at the time of postnatal surgery
Title
Number of days alive in case of postnatal death
Time Frame
during NICU admission

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients aged 18 years or more, who are able to consent Singleton pregnancy Anatomically and chromosomally normal fetus Left sided diaphragmatic hernia Gestation at randomization prior to 31 wks plus 5 d (so that occlusion is done at the latest on 31 wks plus 6 d) Estimated to have moderate pulmonary hypoplasia, defined prenatally as: O/E LHR 25-34.9% (included; irrespective of the position of the liver) O/E LHR 35-44.9% (included) with intrathoracic liver herniation as determined by ultrasound or MRI Acceptance of randomization and the consequences for the further management during pregnancy and thereafter. The patients must undertake the responsibility for either remaining close to, or at the FETO center, or being able to travel swiftly and within acceptable time interval to the FETO center until the balloon is removed. Intended postnatal treatment center must subscribe to suggested guidelines for "standardized postnatal treatment". Provide written consent to participate in this RCT Exclusion Criteria: Maternal contraindication to fetoscopic surgery or severe medical condition in pregnancy that make fetal intervention risk full Technical limitations precluding fetoscopic surgery, such as severe maternal obesity, uterine fibroids or potentially others, not anticipated at the time of writing this protocol. Preterm labour, cervix shortened (<15 mm at randomization) or uterine anomaly strongly predisposing to preterm labour, placenta previa Patient age less than 18 years Psychosocial ineligibility, precluding consent Diaphragmatic hernia: right-sided or bilateral, major anomalies, isolated left-sided outside the O/E LHR limits for the inclusion criteria Patient refusing randomization or to comply with return to FETO center during the time period the airways are occluded or for elective removal of the balloon
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jan A Deprest, MD PhD
Organizational Affiliation
Universitaire Ziekenhuizen KU Leuven
Official's Role
Study Chair
Facility Information:
Facility Name
Baylor College of Medicine/Texas Children's Hospital
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
Facility Name
University of Texas Health Science Center
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
Facility Name
Mater Mother's Hospital
City
Brisbane
State/Province
Queensland
ZIP/Postal Code
4101
Country
Australia
Facility Name
University Hospitals Leuven
City
Leuven
ZIP/Postal Code
3000
Country
Belgium
Facility Name
Mount Sinai Hospital
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5G 1X5
Country
Canada
Facility Name
Hôpital Antoine Béclère
City
Clamart
ZIP/Postal Code
92141
Country
France
Facility Name
Hôpital Necker - Enfants Malades
City
Paris
ZIP/Postal Code
75743
Country
France
Facility Name
University Hospital of Bonn
City
Bonn
ZIP/Postal Code
53105
Country
Germany
Facility Name
Ospedale Maggiore Policlinico
City
Milan
ZIP/Postal Code
20122
Country
Italy
Facility Name
Ospedale Pediatrico Bambino Gesù
City
Rome
ZIP/Postal Code
00123
Country
Italy
Facility Name
1st Department of Obstetrics and Gynecology, Medical University of Warsaw
City
Warsaw
Country
Poland
Facility Name
Hospital Clinic Barcelona
City
Barcelona
State/Province
Catalunya
ZIP/Postal Code
08028
Country
Spain
Facility Name
King's College Hospital
City
London
ZIP/Postal Code
SE5 9RS
Country
United Kingdom

12. IPD Sharing Statement

Citations:
PubMed Identifier
17587219
Citation
Jani J, Nicolaides KH, Keller RL, Benachi A, Peralta CF, Favre R, Moreno O, Tibboel D, Lipitz S, Eggink A, Vaast P, Allegaert K, Harrison M, Deprest J; Antenatal-CDH-Registry Group. Observed to expected lung area to head circumference ratio in the prediction of survival in fetuses with isolated diaphragmatic hernia. Ultrasound Obstet Gynecol. 2007 Jul;30(1):67-71. doi: 10.1002/uog.4052.
Results Reference
background
PubMed Identifier
18634116
Citation
Done E, Gucciardo L, Van Mieghem T, Jani J, Cannie M, Van Schoubroeck D, Devlieger R, Catte LD, Klaritsch P, Mayer S, Beck V, Debeer A, Gratacos E, Nicolaides K, Deprest J. Prenatal diagnosis, prediction of outcome and in utero therapy of isolated congenital diaphragmatic hernia. Prenat Diagn. 2008 Jul;28(7):581-91. doi: 10.1002/pd.2033.
Results Reference
background
PubMed Identifier
16050527
Citation
Deprest J, Jani J, Gratacos E, Vandecruys H, Naulaers G, Delgado J, Greenough A, Nicolaides K; FETO Task Group. Fetal intervention for congenital diaphragmatic hernia: the European experience. Semin Perinatol. 2005 Apr;29(2):94-103. doi: 10.1053/j.semperi.2005.04.006.
Results Reference
background
PubMed Identifier
15287047
Citation
Deprest J, Gratacos E, Nicolaides KH; FETO Task Group. Fetoscopic tracheal occlusion (FETO) for severe congenital diaphragmatic hernia: evolution of a technique and preliminary results. Ultrasound Obstet Gynecol. 2004 Aug;24(2):121-6. doi: 10.1002/uog.1711. Erratum In: Ultrasound Obstet Gynecol. 2004 Oct;24(5):594.
Results Reference
background
PubMed Identifier
19658113
Citation
Jani JC, Nicolaides KH, Gratacos E, Valencia CM, Done E, Martinez JM, Gucciardo L, Cruz R, Deprest JA. Severe diaphragmatic hernia treated by fetal endoscopic tracheal occlusion. Ultrasound Obstet Gynecol. 2009 Sep;34(3):304-10. doi: 10.1002/uog.6450.
Results Reference
background
PubMed Identifier
19559323
Citation
Deprest JA, Gratacos E, Nicolaides K, Done E, Van Mieghem T, Gucciardo L, Claus F, Debeer A, Allegaert K, Reiss I, Tibboel D. Changing perspectives on the perinatal management of isolated congenital diaphragmatic hernia in Europe. Clin Perinatol. 2009 Jun;36(2):329-47, ix. doi: 10.1016/j.clp.2009.03.004.
Results Reference
background
PubMed Identifier
19125386
Citation
Deprest JA, Hyett JA, Flake AW, Nicolaides K, Gratacos E. Current controversies in prenatal diagnosis 4: Should fetal surgery be done in all cases of severe diaphragmatic hernia? Prenat Diagn. 2009 Jan;29(1):15-9. doi: 10.1002/pd.2108. No abstract available.
Results Reference
background
PubMed Identifier
27378767
Citation
Gregoir C, Engels AC, Gomez O, DeKoninck P, Lewi L, Gratacos E, Deprest JA. Fertility, pregnancy and gynecological outcomes after fetoscopic surgery for congenital diaphragmatic hernia. Hum Reprod. 2016 Sep;31(9):2024-30. doi: 10.1093/humrep/dew160. Epub 2016 Jul 4.
Results Reference
background
PubMed Identifier
27077664
Citation
Snoek KG, Reiss IK, Greenough A, Capolupo I, Urlesberger B, Wessel L, Storme L, Deprest J, Schaible T, van Heijst A, Tibboel D; CDH EURO Consortium. Standardized Postnatal Management of Infants with Congenital Diaphragmatic Hernia in Europe: The CDH EURO Consortium Consensus - 2015 Update. Neonatology. 2016;110(1):66-74. doi: 10.1159/000444210. Epub 2016 Apr 15.
Results Reference
background
PubMed Identifier
26135752
Citation
Nawapun K, Eastwood MP, Diaz-Cobos D, Jimenez J, Aertsen M, Gomez O, Claus F, Gratacos E, Deprest J. In vivo evidence by magnetic resonance volumetry of a gestational age dependent response to tracheal occlusion for congenital diaphragmatic hernia. Prenat Diagn. 2015 Nov;35(11):1048-56. doi: 10.1002/pd.4642. Epub 2015 Sep 29.
Results Reference
background
PubMed Identifier
25447987
Citation
Deprest J, Brady P, Nicolaides K, Benachi A, Berg C, Vermeesch J, Gardener G, Gratacos E. Prenatal management of the fetus with isolated congenital diaphragmatic hernia in the era of the TOTAL trial. Semin Fetal Neonatal Med. 2014 Dec;19(6):338-48. doi: 10.1016/j.siny.2014.09.006. Epub 2014 Nov 11.
Results Reference
background
PubMed Identifier
25402437
Citation
Done E, Debeer A, Gucciardo L, Van Mieghem T, Lewi P, Devlieger R, De Catte L, Lewi L, Allegaert K, Deprest J. Prediction of neonatal respiratory function and pulmonary hypertension in fetuses with isolated congenital diaphragmatic hernia in the fetal endoscopic tracleal occlusion era: a single-center study. Fetal Diagn Ther. 2015;37(1):24-32. doi: 10.1159/000364805. Epub 2014 Nov 8.
Results Reference
background
PubMed Identifier
25227954
Citation
DeKoninck P, Gomez O, Sandaite I, Richter J, Nawapun K, Eerdekens A, Ramirez JC, Claus F, Gratacos E, Deprest J. Right-sided congenital diaphragmatic hernia in a decade of fetal surgery. BJOG. 2015 Jun;122(7):940-6. doi: 10.1111/1471-0528.13065. Epub 2014 Sep 17.
Results Reference
background
PubMed Identifier
24284906
Citation
Windrim R, Ryan G, Lebouthillier F, Campisi P, Kelly EN, Baud D, Yoo SJ, Deprest J. Development and use of a high-fidelity simulator for fetal endotracheal balloon occlusion (FETO) insertion and removal. Prenat Diagn. 2014 Feb;34(2):180-4. doi: 10.1002/pd.4284. Epub 2013 Dec 27.
Results Reference
background
PubMed Identifier
23813901
Citation
Engels AC, DeKoninck P, van der Merwe JL, Van Mieghem T, Stevens P, Power B, Nicolaides KH, Gratacos E, Deprest JA. Does website-based information add any value in counseling mothers expecting a baby with severe congenital diaphragmatic hernia? Prenat Diagn. 2013 Nov;33(11):1027-32. doi: 10.1002/pd.4190. Epub 2013 Aug 29.
Results Reference
background
PubMed Identifier
21907109
Citation
Dekoninck P, Gratacos E, Van Mieghem T, Richter J, Lewi P, Ancel AM, Allegaert K, Nicolaides K, Deprest J. Results of fetal endoscopic tracheal occlusion for congenital diaphragmatic hernia and the set up of the randomized controlled TOTAL trial. Early Hum Dev. 2011 Sep;87(9):619-24. doi: 10.1016/j.earlhumdev.2011.08.001.
Results Reference
background
PubMed Identifier
35032132
Citation
Deprest J, Flake A. How should fetal surgery for congenital diaphragmatic hernia be implemented in the post-TOTAL trial era: A discussion. Prenat Diagn. 2022 Mar;42(3):301-309. doi: 10.1002/pd.6091. Epub 2022 Jan 22.
Results Reference
derived
PubMed Identifier
34808130
Citation
Van Calster B, Benachi A, Nicolaides KH, Gratacos E, Berg C, Persico N, Gardener GJ, Belfort M, Ville Y, Ryan G, Johnson A, Sago H, Kosinski P, Bagolan P, Van Mieghem T, DeKoninck PLJ, Russo FM, Hooper SB, Deprest JA. The randomized Tracheal Occlusion To Accelerate Lung growth (TOTAL)-trials on fetal surgery for congenital diaphragmatic hernia: reanalysis using pooled data. Am J Obstet Gynecol. 2022 Apr;226(4):560.e1-560.e24. doi: 10.1016/j.ajog.2021.11.1351. Epub 2021 Nov 19.
Results Reference
derived
PubMed Identifier
34106555
Citation
Deprest JA, Benachi A, Gratacos E, Nicolaides KH, Berg C, Persico N, Belfort M, Gardener GJ, Ville Y, Johnson A, Morini F, Wielgos M, Van Calster B, DeKoninck PLJ; TOTAL Trial for Moderate Hypoplasia Investigators. Randomized Trial of Fetal Surgery for Moderate Left Diaphragmatic Hernia. N Engl J Med. 2021 Jul 8;385(2):119-129. doi: 10.1056/NEJMoa2026983. Epub 2021 Jun 8.
Results Reference
derived
Links:
URL
http://www.euroCDH.org
Description
website on prenatal diagnosis and management of CDH of the FETO consortium
URL
http://www.totaltrial.eu
Description
website of this trial on prenatal management of CDH
URL
http://www.euroCDH.eu
Description
same as www.euroCDH.org
URL
http://www.totaltrial.eu/
Description
same as totaltrial.eu

Learn more about this trial

Fetal Surgery for Moderate Left Sided Congenital Diaphragmatic Hernia.

We'll reach out to this number within 24 hrs